Genomic and Proteomic Analysis of Hepatocellular Carcinogenesis in HBV Transgenic Mice (44.14)

Authors:

Abstract
Hepatitis B virus (HBV) transgenic mice invariably developed macroscopically evident tumors within the 20th month of life. Thus HBV transgenic mouse can be used as a natural model of hepatocellular carcinoma (HCC). We confirmed this phenomenon by observation of BALB/c mice harboring HBV complete genome (subtype ayw). To identify molecular changes involved in HCC, we performed both microarray profiling and proteomic analysis between HBV transgenic mice and their syngeneic controls at 6, 12, and 20-month-old. The total liver RNA was hybridized on an oligonucleotide chip containing 35,000 Mus musculus genes. The total liver protein was used for proteomic analysis. Out of all genes and proteins compared and screened, the number of differentially expressed transcripts and proteins was increased along with the growth of mice. We concluded a molecular portrait in different stages of HCC. These molecules were involved in important cellular pathways, including cell growth regulation, apoptosis, immune response, metabolisms, stress, cell adhesion, et al. The dynamics of molecular profiling during hepatocellular carcinogenesis would better elucidate the molecular mechanisms of HCC and help for the discovery of novel therapeutic targets. Correspondence to Wensheng Sun: wsw@sdu.edu.cn Supported by the National Nature Science Foundation of China, Grant No. 30440040, 30772031, and 30801036.